Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis
Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis
TP53 status and licensing complex/IFNγ transcriptional profiles to stratify endocrine-related outcomes withCDK4/6i exposure in 10,833 real-world ER+/HER2- breast cancers and a treatment-naïve subset